Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Viscosupplementation for Knee Osteoarthritis
NCT03491761Phase 2Recruiting
- Sponsor
- Endeavor Health
- Start
- Jun 2018
- Primary completion
- Dec 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of platelet-rich plasma in knee osteoarthritis (OA) (2 arms), sponsored by Endeavor Health. Primary endpoint: Cartilage Thickness on MRI at 12 months. Started Jun 2018; status: recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03491761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03491761.